Your browser doesn't support javascript.
loading
Genome-wide association study identifies 30 obsessive-compulsive disorder associated loci.
Strom, Nora I; Gerring, Zachary F; Galimberti, Marco; Yu, Dongmei; Halvorsen, Matthew W; Abdellaoui, Abdel; Rodriguez-Fontenla, Cristina; Sealock, Julia M; Bigdeli, Tim; Coleman, Jonathan R; Mahjani, Behrang; Thorp, Jackson G; Bey, Katharina; Burton, Christie L; Luykx, Jurjen J; Zai, Gwyneth; Alemany, Silvia; Andre, Christine; Askland, Kathleen D; Banaj, Nerisa; Barlassina, Cristina; Nissen, Judith Becker; Bienvenu, O Joseph; Black, Donald; Bloch, Michael H; Boberg, Julia; Børte, Sigrid; Bosch, Rosa; Breen, Michael; Brennan, Brian P; Brentani, Helena; Buxbaum, Joseph D; Bybjerg-Grauholm, Jonas; Byrne, Enda M; Cabana-Dominguez, Judit; Camarena, Beatriz; Camarena, Adrian; Cappi, Carolina; Carracedo, Angel; Casas, Miguel; Cavallini, Maria Cristina; Ciullo, Valentina; Cook, Edwin H; Crosby, Jesse; Cullen, Bernadette A; De Schipper, Elles J; Delorme, Richard; Djurovic, Srdjan; Elias, Jason A; Estivill, Xavier.
Affiliation
  • Strom NI; Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Gerring ZF; Department of Psychiatric Phenomics and Genomics (IPPG), Ludwig-Maximilians University Munich, Munich, Germany.
  • Galimberti M; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Services, Region Stockholm , Stockholm, Sweden.
  • Yu D; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  • Halvorsen MW; Department of Mental Health and Neuroscience, Translational Neurogenomics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Abdellaoui A; Department of Population Health and Immunity, Healthy Development and Ageing, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Rodriguez-Fontenla C; Department of Psychiatry, Human Genetics, Yale University, New Haven, CT, USA.
  • Sealock JM; VA Connecticut Healthcare System, West Haven, CT, USA.
  • Bigdeli T; Department of Center for Genomic Medicine, Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
  • Coleman JR; Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA, USA.
  • Mahjani B; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Thorp JG; Department of Psychiatry, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Bey K; CIMUS (Center for Research in Molecular Medicine and Chronic Diseases), Genomics and Bioinformatics, University of Santiago de Compostela, Santiago de Compostela, A Coruña, Spain.
  • Burton CL; Grupo de Medicina Xenómica, Genetics, FIDIS (Instituto de Investigación Sanitaria de Santiago de Compostela), Santiago de Compostela, A Coruña, Spain.
  • Luykx JJ; Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.
  • Zai G; Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, NY, USA.
  • Alemany S; VA NY Harbor Healthcare System, Brooklyn, NY, USA.
  • Andre C; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.
  • Askland KD; National Institute for Health and Care Research Maudsley Biomedical Research Centre, South London and Maudsley NHS Trust, London, United Kingdom.
  • Banaj N; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Barlassina C; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Nissen JB; Mental Health and Neuroscience Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Bienvenu OJ; Faculty of Medicine, School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.
  • Black D; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.
  • Bloch MH; Department of Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada.
  • Boberg J; Department of Psychiatry, Brain, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Børte S; Second opinion outpatient clinic, GGNet, Warnsveld, The Netherlands.
  • Bosch R; Molecular Brain Science Department, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health,, Toronto, ON, Canada.
  • Breen M; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Brennan BP; Psychiatric Genetics Unit, Group of Psychiatry, Mental Health and Addiction, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Brentani H; Department of Mental Health, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Buxbaum JD; Biomedical Network Research Centre on Mental Health (CIBERSAM), Madrid, Spain.
  • Bybjerg-Grauholm J; Obsessive-Compulsive Disorder Institute, McLean Hospital, Belmont, MA, USA.
  • Byrne EM; Department of Psychiatry & Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.
  • Cabana-Dominguez J; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Camarena B; Department of Heath Sciences, University of Milano, Milano, Italy.
  • Camarena A; Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Psychiatry, Aarhus, Denmark.
  • Cappi C; Institute of Clinical Medicine, Health, Aarhus University, Aarhus, Denmark.
  • Carracedo A; Department of Psychiatry and Behavioral Sciences, General Hospital Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Casas M; Departments of Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Cavallini MC; Department of Child Study Center and Psychiatry, Yale University, New Haven, CT, USA.
  • Ciullo V; Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Services, Region Stockholm , Stockholm, Sweden.
  • Cook EH; Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
  • Crosby J; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, HUNT Center for Molecular and Clinical Epidemiology, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
  • Cullen BA; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • De Schipper EJ; Department of Child and Adolescent Mental Health, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.
  • Delorme R; Instituto de Salut Carlos III, Centro de Investigación Biomédica en Red de Salut Mental (CIBERSAM), Madrid, Spain.
  • Djurovic S; Department of Psychiatry, Icahn School of Medicine At Mount Sinai, New York, NY, USA.
  • Elias JA; Seaver Autism Center for Research and Treatment, Icahn School of Medicine At Mount Sinai, New York, NY, USA.
  • Estivill X; The Mindich Child Health and Development Institute, Icahn School of Medicine At Mount Sinai, New York, NY, USA.
medRxiv ; 2024 Mar 13.
Article in En | MEDLINE | ID: mdl-38712091
ABSTRACT
Obsessive-compulsive disorder (OCD) affects ~1% of the population and exhibits a high SNP-heritability, yet previous genome-wide association studies (GWAS) have provided limited information on the genetic etiology and underlying biological mechanisms of the disorder. We conducted a GWAS meta-analysis combining 53,660 OCD cases and 2,044,417 controls from 28 European-ancestry cohorts revealing 30 independent genome-wide significant SNPs and a SNP-based heritability of 6.7%. Separate GWAS for clinical, biobank, comorbid, and self-report sub-groups found no evidence of sample ascertainment impacting our results. Functional and positional QTL gene-based approaches identified 249 significant candidate risk genes for OCD, of which 25 were identified as putatively causal, highlighting WDR6, DALRD3, CTNND1 and genes in the MHC region. Tissue and single-cell enrichment analyses highlighted hippocampal and cortical excitatory neurons, along with D1- and D2-type dopamine receptor-containing medium spiny neurons, as playing a role in OCD risk. OCD displayed significant genetic correlations with 65 out of 112 examined phenotypes. Notably, it showed positive genetic correlations with all included psychiatric phenotypes, in particular anxiety, depression, anorexia nervosa, and Tourette syndrome, and negative correlations with a subset of the included autoimmune disorders, educational attainment, and body mass index.. This study marks a significant step toward unraveling its genetic landscape and advances understanding of OCD genetics, providing a foundation for future interventions to address this debilitating disorder.

Full text: 1 Database: MEDLINE Language: En Journal: MedRxiv Year: 2024 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Language: En Journal: MedRxiv Year: 2024 Type: Article Affiliation country: Germany